Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 19, 2016 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271

WATERTOWN, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the initiation of patient dosing in a phase 1 clinical trial for intravenous (IV)...
December 03, 2015 09:11 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference

WATERTOWN, Mass., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
November 12, 2015 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Provide Corporate Update at Stifel 2015 Healthcare Conference

WATERTOWN, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
November 02, 2015 07:30 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Reports Third-Quarter 2015 Financial Results

WATERTOWN, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
October 07, 2015 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Eravacycline Data Supporting Activity Against Multidrug-Resistant Gram-Negative Bacteria to be Presented at IDWeek 2015

WATERTOWN, Mass., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
September 08, 2015 16:01 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Announces Top-Line Results From IGNITE2 Phase 3 Clinical Trial of Eravacycline in cUTI

Eravacycline Did Not Achieve Primary Endpoint in Pivotal Portion of cUTI Trial Company to Host Conference Call at 4:30 p.m. ET Today WATERTOWN, Mass., Sept. 8, 2015 (GLOBE NEWSWIRE) --...
September 03, 2015 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

FDA Grants QIDP Designation and Fast Track Status to TP-271

WATERTOWN, Mass., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious...
August 25, 2015 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at ICAAC/ICC 2015

WATERTOWN, Mass., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that 11 data presentations at the Interscience Conference of Antimicrobial Agents and...
August 06, 2015 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

WATERTOWN, Mass., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
August 05, 2015 16:01 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

WATERTOWN, Mass., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...